The same active ingredient
Ozempic® and Wegovy® are two of the most talked-about names in weight loss, and they share one important fact: both contain the exact same active ingredient — semaglutide — made by the same manufacturer (Novo Nordisk). The difference isn't the molecule. It's what each version is FDA-approved to do, and the dose it's given at.
Ozempic® is approved to improve blood sugar in adults with type 2 diabetes. Wegovy® is approved specifically for chronic weight management in eligible adults and adolescents. Same drug, two different official uses.
Different doses, different labels
Because the two products target different goals, they're dosed differently. Wegovy® is titrated up to a higher maintenance dose (2.4 mg) studied specifically for weight loss, while Ozempic®'s dosing tops out lower for blood-sugar control. That higher dose is part of why Wegovy® is the version formally indicated for weight management.
You may still hear about people taking Ozempic® for weight loss — that's an "off-label" use decided between a patient and their provider. It's legal and common, but it's a clinical judgment, not an official indication.
Why the confusion?
Three things blurred the line in the public mind: the two products share a molecule, social media turned "Ozempic" into a catch-all nickname for the whole category, and periodic shortages pushed patients and providers to switch between versions. Add compounded semaglutide to the mix and it's easy to see why people aren't sure what they're actually taking.
What this means for you
The practical takeaway: which semaglutide product is right for you depends on your health goals, eligibility, insurance, and availability — and that's a decision for a licensed provider, not a guess. Many online programs also offer compounded semaglutide as a more affordable cash-pay option. Whichever route you explore, make sure a licensed clinician reviews your history and oversees your treatment.